BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study Reuters, 6 Oct 2014 Accessed on 14 Oct 2014 from http://www.reuters.com/article/2014/10/06/absciencesa-brief-idUSFWN0S100120141006. CommentRecommendBookmarkWatch